CFGS
SLXN

Concourse Financial Group Securities’s Silexion Therapeutics SLXN Stock Holding History

Concourse Financial Group Securities’s Portfolio SLXN Stock Details SLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– – – 9361
2024
Q4 		– Hold
0
– – – 9401
2024
Q3 		– Hold
0
– – – 9405